Unique Ingredient Identifier 4550K0SC9B is listed as a ingredient substance
| RN | 6131-90-4 |
| NCIT | C47720 |
| RXCUI | 237108 |
| PUBCHEM | 23665404 |
| MF | C2H3O2.Na.3H2O |
| INCHI KEY | AYRVGWHSXIMRAB-UHFFFAOYSA-M |
| SMILES | O.O.O.[Na+].CC([O-])=O |
UNII 4550K0SC9B SODIUM ACETATE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,INFILTRATION | INJECTION | 0.38 % |
| AURICULAR (OTIC) | SOLUTION | 0.075 % |
| AURICULAR (OTIC) | SOLUTION, DROPS | 0.027 % |
| AURICULAR (OTIC) | SUSPENSION | 0.042 % |
| AURICULAR (OTIC) | SUSPENSION, LIQUID | 0.68 % |
| EXTRACORPOREAL | SOLUTION | 0.18 % |
| IM - IV | INJECTION | 0.97 % |
| IM - IV - SC | INJECTION | 0.65 % |
| IM - SC | INJECTION | 0.2 % |
| INTERSTITIAL | INJECTION | NA |
| INTRA-ARTICULAR | INJECTION | ADJPH |
| INTRACAVITARY | INJECTION | NA |
| INTRADERMAL | INJECTION | 0.16 % |
| INTRALESIONAL | INJECTION | ADJPH |
| INTRAMUSCULAR | INJECTION | 0.4 %W/V |
| INTRAOCULAR | SOLUTION | 0.39 % |
| INTRAPERITONEAL | INJECTION | NA |
| INTRAPLEURAL | INJECTION | NA |
| INTRASYNOVIAL | INJECTION | ADJPH |
| INTRAVENOUS | INJECTABLE | 0.2 mg/1mL |
| INTRAVENOUS | INJECTABLE | 0.2 % |
| INTRAVENOUS | INJECTION | 20.4 % |
| INTRAVENOUS | INJECTION | 1.64 MG/ML |
| INTRAVENOUS | INJECTION, SOLUTION | 0.2 MG/1ML |
| INTRAVENOUS | INJECTION, SOLUTION | 0.04 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 12.5 % |
| INTRAVENOUS | SOLUTION | 0.2 mg/1mL |
| INTRAVENOUS | SOLUTION | NA |
| INTRAVENOUS | SOLUTION, INJECTION | 2 % |
| INTRAVENOUS INFUSION | INJECTION, SOLUTION | 0.04 % |
| INTRAVITREAL | SUSPENSION, INJECTION | 0.39 % |
| IV - SC | INJECTION | 0.2 % |
| IV - SC | LIQUID | 0.2 % |
| IV(INFUSION) | INJECTABLE | 0.16 % |
| IV(INFUSION) | INJECTION | 59.4 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 6.25 % |
| IV(INFUSION) | SOLUTION, INJECTION | 0.68 % |
| NASAL | SOLUTION | NA |
| NERVE BLOCK | INJECTION | 0.38 % |
| OPHTHALMIC | EMULSION | 0.05 % |
| OPHTHALMIC | POWDER, FOR SOLUTION | 0.39 % |
| OPHTHALMIC | SOLUTION | 1.25 % |
| OPHTHALMIC | SOLUTION, DROPS | 1.28 % |
| ORAL | CONCENTRATE | NA |
| ORAL | POWDER, FOR SOLUTION | 99.3 MG/1GM |
| ORAL | SOLUTION | 3400 MG/1000ML |
| ORAL | SOLUTION, INJECTION | 1.36 MG/1.7ML |
| ORAL | SOLUTION, SYRUP | 7.2 MG/5ML |
| ORAL | SYRUP | 21.45 MG/5ML |
| OTIC | SUSPENSION | 0.03 % |
| PARENTERAL | INJECTABLE | 0.16 % |
| PARENTERAL | INJECTION | 10.37 % |
| PARENTERAL | POWDER, FOR INJECTION SOLUTION | 1.25 % |
| PHOTOPHERESIS | SOLUTION | 0.18 % |
| SOFT TISSUE | INJECTION | ADJPH |
| SUBCUTANEOUS | INJECTABLE | 0.2 % |
| SUBCUTANEOUS | INJECTION | 0.2 % |
| SUBCUTANEOUS | LIQUID | 0.15 % |
| SUBCUTANEOUS | SOLUTION | 0.023 % |
| SUBCUTANEOUS | SOLUTION, INJECTION | 0.35 % |
| SUBMUCOSAL | SOLUTION, INJECTION | 0.08 % |
| TOPICAL | EMULSION, CREAM | NA |
| TOPICAL | SOLUTION | 0.3 MG/1ML |